AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 32(4), 1983, pp. 727-732
Copyright © 1983 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knobloch, J.
Right arrow Articles by Mannweiler, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knobloch, J.
Right arrow Articles by Mannweiler, E.

Development and Persistence of Antibodies to Entamoeba Histolytica in Patients with Amebic Liver Abscess

Analysis of 216 Cases*

Jürgen Knobloch AND Erich Mannweiler
Department of Bacteriology and Serology, Bernhard-Nocht-Institute for Maritime and Tropical Diseases, Hamburg, Federal Republic of Germany

The antibody patterns—obtained by enzyme immunoassay (EIA), complement fixation (CF), indirect hemagglutination (IHA), and latex agglutination (LA)—of 216 patients with amebic liver abscess (ALA) were related to the time of onset of illness and to epidemiological data. The usual period between the stay in an Entamoeba histolytica-endemic area and clinical manifestation of the disease was 8–20 weeks. Increasing antibody concentration affected the sensitivity rates for CF and LA in the first 3 weeks of clinical ALA. In comparison with CF, IHA, and LA, EIA was the most sensitive test, showed the most substantial changes in antibody concentration according to the stage of disease, and measured persisting antibodies for the longest period. Neither the duration of previous stay in tropical countries nor the time when specific chemotherapy was started influenced development or persistence of antibodies in ALA patients. ALA occurred with similar frequency regardless of whether the patient was a long-term resident of the tropics or a short-term visitor to an E. histolytica-endemic area.

Accepted for publication August 20, 1982.


* Address reprint requests to: Dr. Jürgen Knobloch, Abteilung für Bakteriologie und Serologie, Bernhard-Nocht-Institut für Schiffs- und Tropenkrankheiten, Bernhard-Nocht-Strasse 74, D-2000 Hamburg 4, FR Germany.




This article has been cited by other articles:


Home page
NEJMHome page
J. P. Daily and M. A. Waldron
Case 22-2003 - A 22-Year-Old Man with Chills and Fever after a Stay in South America
N. Engl. J. Med., July 17, 2003; 349(3): 287 - 295.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Society of Tropical Medicine and Hygiene.